As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...

As liver fibrosis can lead to cirrhosis and increase the risk of liver-related complications, understanding factors that ...

Hepatic steatosis steadily increased in patients with HIV and HCV coinfection despite curative treatment with DAA therapy.

ALASTAIR Cook was told he had terminal liver cancer in July 2024. His devastating diagnosis was caused by a ‘silent killer’ virus he got after a traumatic car crash almost four decades ...

New Gene Therapy for Muscular Dystrophy Offers Hope July 17, 2024 — A new gene therapy treatment for Duchenne muscular dystrophy (DMD) shows promise of not only arresting the decline of the ...

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's ...

The 19th reports that for those living with HIV, extreme weather events make it more difficult to stay on top of medications. In separate climate news, rising temperatures may propel a wider spread of ...

Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit ...

William Blair has the equivalent of a buy rating on the stock, as do all 13 analysts offering coverage of the stock on FactSet. The bank is one of many expecting Viking to be a takeover target, given ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

On Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) highlighted the final results from its VOYAGE Phase 2b trial of VK2809 in ...

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led ...